Cite
High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study.
MLA
Höfl, Reinhard, et al. “High Prevalence of High Risk Human Papillomavirus-Capsid Antibodies in Human Immunodeficiency Virus-Seropositive Men: A Serological Study.” BMC Infectious Diseases, vol. 3, no. 1, Jan. 2003, pp. 6–8. EBSCOhost, https://doi.org/10.1186/1471-2334-3-6.
APA
Höfl, R., Petter, A., Thaler, P., Sarcletti, M., Widschwendter, A., & Zangerle, R. (2003). High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study. BMC Infectious Diseases, 3(1), 6–8. https://doi.org/10.1186/1471-2334-3-6
Chicago
Höfl, Reinhard, Anton Petter, Petra Thaler, Mario Sarcletti, Andreas Widschwendter, and Robert Zangerle. 2003. “High Prevalence of High Risk Human Papillomavirus-Capsid Antibodies in Human Immunodeficiency Virus-Seropositive Men: A Serological Study.” BMC Infectious Diseases 3 (1): 6–8. doi:10.1186/1471-2334-3-6.